FDA Staff Find Few Faults with Pfizer-BioNTech COVID-19 Vax

(MedPage Today) -- The Pfizer-BioNTech mRNA COVID-19 vaccine candidate (BNT162b2) appeared to meet criteria for an emergency use authorization, with no major concerns raised by FDA staff in a briefing document released by the agency Tuesday.
In...